Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2014 2
2015 2
2016 4
2017 3
2018 6
2019 7
2020 6
2021 11
2022 14
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G, Fazeli Farsani S, Patorno E, Núñez J; EMPRISE Europe and Asia Study Group. Karasik A, et al. Among authors: lanzinger s. Diabetes Metab. 2023 Mar;49(2):101418. doi: 10.1016/j.diabet.2022.101418. Epub 2023 Jan 3. Diabetes Metab. 2023. PMID: 36608816 Free article.
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K; EMPRISE EU; East Asia Study Group. Vistisen D, et al. Among authors: lanzinger s. Cardiovasc Diabetol. 2023 Aug 31;22(1):233. doi: 10.1186/s12933-023-01963-9. Cardiovasc Diabetol. 2023. PMID: 37653496 Free PMC article.
A collaborative comparison of international pediatric diabetes registries.
Lanzinger S, Zimmermann A, Ranjan AG, Gani O, Pons Perez S, Akesson K, Majidi S, Witsch M, Hofer S, Johnson S, Pilgaard KA, Kummernes SJ, Robinson H, Eeg-Olofsson K, Ebekozien O, Holl RW, Svensson J, Skrivarhaug T, Warner J, Craig ME, Maahs D; Australasian Diabetes Data Network (ADDN), Danish Registry of Childhood and Adolescent Diabetes (DanDiabKids), Diabetes prospective follow-up registry (DPV), Norwegian Childhood Diabetes Registry (NCDR), National Paediatric Diabetes Audit (NPDA), Swedish Childhood Diabetes Registry (Swediabkids), T1D Exchange Quality Improvement Collaborative (T1DX-QI), and SWEET initiative. Lanzinger S, et al. Pediatr Diabetes. 2022 Sep;23(6):627-640. doi: 10.1111/pedi.13362. Epub 2022 May 30. Pediatr Diabetes. 2022. PMID: 35561091
Demographic, Clinical, Management, and Outcome Characteristics of 8,004 Young Children With Type 1 Diabetes.
Sandy JL, Tittel SR, Rompicherla S, Karges B, James S, Rioles N, Zimmerman AG, Fröhlich-Reiterer E, Maahs DM, Lanzinger S, Craig ME, Ebekozien O; Australasian Diabetes Data Network (ADDN); T1D Exchanged Quality Improvement Collaborative (T1DX-QI); Prospective Diabetes Follow-Up Registry Initiative (DPV). Sandy JL, et al. Among authors: lanzinger s. Diabetes Care. 2024 Apr 1;47(4):660-667. doi: 10.2337/dc23-1317. Diabetes Care. 2024. PMID: 38305782
Adalimumab-induced aseptic meningitis in a patient with rheumatoid arthritis.
Berti P, Schwarz A, Pirillo V, Lanzinger S, Kluge R, Cagini A, Karner M, Zampogna G, Dejaco C. Berti P, et al. Among authors: lanzinger s. Joint Bone Spine. 2022 Jul;89(4):105356. doi: 10.1016/j.jbspin.2022.105356. Epub 2022 Feb 12. Joint Bone Spine. 2022. PMID: 35167970 No abstract available.
Comorbidities in Recent-Onset Adult Type 1 Diabetes: A Comparison of German Cohorts.
Zaharia OP, Lanzinger S, Rosenbauer J, Karges W, Müssig K, Meyhöfer SM, Burkart V, Hummel M, Raddatz D, Roden M, Szendroedi J, Holl RW. Zaharia OP, et al. Among authors: lanzinger s. Front Endocrinol (Lausanne). 2022 Jun 3;13:760778. doi: 10.3389/fendo.2022.760778. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721726 Free PMC article.
Worldwide differences in childhood type 1 diabetes: The SWEET experience.
Saiyed M, Hasnani D, Alonso GT, Richmond E, Besançon S, Cotterill A, Ngwu U, Mazza C, Rottembourg D, Lanzinger S; SWEET study group. Saiyed M, et al. Among authors: lanzinger s. Pediatr Diabetes. 2021 Mar;22(2):207-214. doi: 10.1111/pedi.13137. Epub 2020 Oct 22. Pediatr Diabetes. 2021. PMID: 33038056
64 results